Interestingly, among the ENOX2 transcript variants with the greatest incidence, 16 and 20%, were those characteristic of breast and non-small cell lung cancer, two cancers generally regarded as characterized by extended latency periods perhaps even as long as 20 years [5,19]. This evidence concerns the gene ENOX2 and non-small cell lung carcinoma.